The Korean Journal of Gastroenterology (대한소화기학회지)

The Korean Society of Gastroenterology (대한소화기학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial

  • Shadnoush, Mahdi (National Nutrition and Food Technology Research Institute, Faculty of Nutrition Sciences and Food Technology) ;
  • Hosseini, Rahebeh Shaker (National Nutrition and Food Technology Research Institute, Faculty of Nutrition Sciences and Food Technology) ;
  • Khalilnezhad, Ahad (Department of Immunology, Medical School, Shahid Beheshti University of Medical Sciences) ;
  • Navai, Lida (Department of Clinical Nutrition and Dietetics, National Nutrition and Food Technology Research Institute, Faculty of Nutrition Sciences and Food Technology) ;
  • Goudarzi, Hossein (Department of Microbiology, Medical School, Shahid Beheshti University of Medical Sciences) ;
  • Vaezjalali, Maryam (Department of Microbiology, Medical School, Shahid Beheshti University of Medical Sciences)
  • Received : 2014.06.25
  • Accepted : 2015.03.02
  • Published : 2015.04.25
⟨ Previous Next ⟩

Abstract

Background/Aims: Several clinical trials have revealed various advantages for probiotics in inflammatory bowel disease (IBD). The aim of this study was to further investigate the effects of probiotic yogurt consumption on gut microbiota in patients with this disease. Methods: A total of 305 participants were divided into three groups; group A (IBD patients receiving probiotic yogurt; n=105), group B (IBD patients receiving placebo; n=105), and control group (healthy individuals receiving probiotic yogurt; n=95). Stool samples were collected both before and after 8 weeks of intervention; and population of Lactobacillus, Bifidobacterium and Bacteroides in the stool specimens was measured by Taqman real-time PCR method. Results: By the end of the intervention, no significant variations in the mean weight and body mass index were observed between three groups (p>0.05). However, the mean numbers of Lactobacillus, Bifidobacterium, and Bacteroides in group A were significantly increased compared to group B (p<0.001, p<0.001, and p<0.01, respectively). There were also significant differences in the mean numbers of either of three bacteria between group A and the healthy control group; however, these differences between two groups were observed both at baseline and the end of the intervention. Conclusions: Consumption of probiotic yogurt by patients with IBD may help to improve intestinal function by increasing the number of probiotic bacteria in the intestine and colon. However, many more studies are required in order to prove the concept.

Keywords

References

  1. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet 2007;369:1627-1640. https://doi.org/10.1016/S0140-6736(07)60750-8
  2. Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 2006;12(Suppl 1):S3-S9.
  3. Karlinger K, Gyorke T, Mako E, Mester A, Tarjan Z. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol 2000;35:154-167. https://doi.org/10.1016/S0720-048X(00)00238-2
  4. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007;5:1424-1429. https://doi.org/10.1016/j.cgh.2007.07.012
  5. Orel R, Kamhi T, Vidmar G, Mamula P. Epidemiology of pediatric chronic inflammatory bowel disease in central and western Slovenia, 1994-2005. J Pediatr Gastroenterol Nutr 2009;48: 579-586. https://doi.org/10.1097/MPG.0b013e318164d903
  6. Lakatos PL, Fischer S, Lakatos L. Is the epidemiology of inflammatory bowel disease changing in Eastern Europe? Scand J Gastroenterol 2006;41:870-871. https://doi.org/10.1080/00365520600636167
  7. Lovasz BD, Golovics PA, Vegh Z, Lakatos PL. New trends in inflammatory bowel disease epidemiology and disease course in Eastern Europe. Dig Liver Dis 2013;45:269-276. https://doi.org/10.1016/j.dld.2012.08.020
  8. Hou JK, Kramer JR, Richardson P, Mei M, El-Serag HB. The incidence and prevalence of inflammatory bowel disease among U.S. veterans: a national cohort study. Inflamm Bowel Dis 2013;19:1059-1064. https://doi.org/10.1097/MIB.0b013e31828028ca
  9. Thia KT, Loftus EV Jr, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 2008;103:3167-3182. https://doi.org/10.1111/j.1572-0241.2008.02158.x
  10. Vahedi H, Merat S, Momtahen S, et al. Epidemiologic characteristics of 500 patients with inflammatory bowel disease in Iran studied from 2004 through 2007. Arch Iran Med 2009;12:454-460.
  11. Aghazadeh R, Zali MR, Bahari A, Amin K, Ghahghaie F, Firouzi F. Inflammatory bowel disease in Iran: a review of 457 cases. J Gastroenterol Hepatol 2005;20:1691-1695. https://doi.org/10.1111/j.1440-1746.2005.03905.x
  12. Shamir R. Nutrition and growth in inflammatory bowel disease. World Rev Nutr Diet 2013;106:156-161.
  13. Gentschew L, Ferguson LR. Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Mol Nutr Food Res 2012;56:524-535. https://doi.org/10.1002/mnfr.201100630
  14. Hakansson A, Molin G. Gut microbiota and inflammation. Nutrients 2011;3:637-682. https://doi.org/10.3390/nu3060637
  15. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577-594. https://doi.org/10.1053/j.gastro.2007.11.059
  16. Quigley EM. Gut microbiota and the role of probiotics in therapy. Curr Opin Pharmacol 2011;11:593-603. https://doi.org/10.1016/j.coph.2011.09.010
  17. Iannitti T, Palmieri B. Therapeutical use of probiotic formulations in clinical practice. Clin Nutr 2010;29:701-725. https://doi.org/10.1016/j.clnu.2010.05.004
  18. Asakura H, Suzuki K, Honma T. Recent advances in basic and clinical aspects of inflammatory bowel disease: which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease? World J Gastroenterol 2007;13: 2145-2149. https://doi.org/10.3748/wjg.v13.i15.2145
  19. Mai V, Draganov PV. Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health. World J Gastroenterol 2009;15:81-85. https://doi.org/10.3748/wjg.15.81
  20. Steer T, Carpenter H, Tuohy K, Gibson GR. Perspectives on the role of the human gut microbiota and its modulation by pro- and prebiotics. Nutr Res Rev 2000;13:229-254. https://doi.org/10.1079/095442200108729089
  21. Othman M, Aguero R, Lin HC. Alterations in intestinal microbial flora and human disease. Curr Opin Gastroenterol 2008;24:11-16. https://doi.org/10.1097/MOG.0b013e3282f2b0d7
  22. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995;125:1401-1412.
  23. O'Mahony L, Feeney M, O'Halloran S, et al. Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment Pharmacol Ther 2001;15:1219-1225. https://doi.org/10.1046/j.1365-2036.2001.01027.x
  24. Prisciandaro L, Geier M, Butler R, Cummins A, Howarth G. Probiotics and their derivatives as treatments for inflammatory bowel disease. Inflamm Bowel Dis 2009;15:1906-1914. https://doi.org/10.1002/ibd.20938
  25. Meijer BJ, Dieleman LA. Probiotics in the treatment of human inflammatory bowel diseases: update 2011. J Clin Gastroenterol 2011;45(Suppl):S139-S144. https://doi.org/10.1097/MCG.0b013e31822103f7
  26. Brown AC, Valiere A. Probiotics and medical nutrition therapy. Nutr Clin Care 2004;7:56-68.
  27. Pineda Mde L, Thompson SF, Summers K, de Leon F, Pope J, Reid G. A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. Med Sci Monit 2011;17:CR347-CR354.
  28. Cui HH, Chen CL, Wang JD, et al. Effects of probiotic on intestinal mucosa of patients with ulcerative colitis. World J Gastroenterol 2004;10:1521-1525. https://doi.org/10.3748/wjg.v10.i10.1521
  29. Lorea Baroja M, Kirjavainen PV, Hekmat S, Reid G. Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin Exp Immunol 2007;149:470-479. https://doi.org/10.1111/j.1365-2249.2007.03434.x
  30. Veerappan GR, Betteridge J, Young PE. Probiotics for the treatment of inflammatory bowel disease. Curr Gastroenterol Rep 2012;14:324-333. https://doi.org/10.1007/s11894-012-0265-5
  31. Malin M, Suomalainen H, Saxelin M, Isolauri E. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab 1996;40: 137-145. https://doi.org/10.1159/000177907
  32. Mach T. Clinical usefulness of probiotics in inflammatory bowel diseases. J Physiol Pharmacol 2006;57(Suppl 9):23-33.
  33. Ishikawa H, Akedo I, Umesaki Y, Tanaka R, Imaoka A, Otani T. Randomized controlled trial of the effect of Bifidobacteria-fermented milk on ulcerative colitis. J Am Coll Nutr 2003;22:56-63. https://doi.org/10.1080/07315724.2003.10719276
  34. Kato K, Mizuno S, Umesaki Y, et al. Randomized placebo-controlled trial assessing the effect of Bifidobacteria-fermented milk on active ulcerative colitis. Aliment Pharmacol Ther 2004; 20:1133-1141. https://doi.org/10.1111/j.1365-2036.2004.02268.x
  35. Fedorak R, Demeria D. Probiotic bacteria in the prevention and the treatment of inflammatory bowel disease. Gastroenterol Clin North Am 2012;41:821-842. https://doi.org/10.1016/j.gtc.2012.08.003
  36. Macfarlane S, Steed H, Macfarlane GT. Intestinal bacteria and inflammatory bowel disease. Crit Rev Clin Lab Sci 2009;46:25-54. https://doi.org/10.1080/10408360802485792
  37. Kim E, Yune S, Ha JM, et al. Predictive factors of response to medical therapy in Crohn's disease patients with intestinal obstruction. Korean J Gastroenterol 2013;62:213-218. https://doi.org/10.4166/kjg.2013.62.4.213
  38. Venturi A, Gionchetti P, Rizzello F, et al. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther 1999;13:1103-1108. https://doi.org/10.1046/j.1365-2036.1999.00560.x
  39. Garcia-Albiach R, Pozuelo de Felipe MJ, Angulo S, et al. Molecular analysis of yogurt containing Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus thermophilus in human intestinal microbiota. Am J Clin Nutr 2008;87:91-96. https://doi.org/10.1093/ajcn/87.1.91
  40. Tannock GW, Munro K, Harmsen HJ, Welling GW, Smart J, Gopal PK. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol 2000;66:2578-2588. https://doi.org/10.1128/AEM.66.6.2578-2588.2000
  41. Uyeno Y, Sekiguchi Y, Kamagata Y. Impact of consumption of probiotic Lactobacilli-containing yogurt on microbial composition in human feces. Int J Food Microbiol 2008;122:16-22. https://doi.org/10.1016/j.ijfoodmicro.2007.11.042
  42. Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 2012;9:599-608. https://doi.org/10.1038/nrgastro.2012.152

Cited by

  1. Clinical Roundup: Selected Treatment Options for Inflammatory Bowel Disease vol.21, pp.6, 2015, https://doi.org/10.1089/act.2015.29032.cru
  2. The Current and Future Role of Drugs and Probiotics in the Management of Inflammatory Bowel Disease vol.3, pp.8, 2015, https://doi.org/10.4236/jbm.2015.38008
  3. Probiotics and Inflammatory Pain: A Literature Review Study vol.3, pp.2, 2015, https://doi.org/10.17795/mejrh-36087
  4. Gut microbiome in children with enthesitis‐related arthritis in a developing country and the effect of probiotic administration vol.187, pp.3, 2015, https://doi.org/10.1111/cei.12900
  5. Effect of Probiotic Administration on Acute Inflammatory Pain vol.4, pp.1, 2015, https://doi.org/10.17795/mejrh-42022
  6. Implications of Probiotics on the Maternal-Neonatal Interface: Gut Microbiota, Immunomodulation, and Autoimmunity vol.9, pp.None, 2015, https://doi.org/10.3389/fimmu.2018.02840
  7. Implications of the Westernized Diet in the Onset and Progression of IBD vol.11, pp.5, 2015, https://doi.org/10.3390/nu11051033
  8. Diet as an environmental trigger in inflammatory bowel disease: a retrospective comparative study in two European cohorts vol.112, pp.None, 2015, https://doi.org/10.17235/reed.2020.6552/2019
  9. Probiotics in inflammatory bowel disease: Does it work? vol.8, pp.2, 2015, https://doi.org/10.13105/wjma.v8.i2.54
  10. Does Consumption of Fermented Foods Modify the Human Gut Microbiota? vol.150, pp.7, 2015, https://doi.org/10.1093/jn/nxaa077
  11. Effects of prebiotic dietary fibers and probiotics on human health: With special focus on recent advancement in their encapsulated formulations vol.102, pp.None, 2015, https://doi.org/10.1016/j.tifs.2020.06.010
  12. Probiotics as a Coadjuvant Factor in Active or Quiescent Inflammatory Bowel Disease of Adults—A Meta-Analytical Study vol.12, pp.9, 2015, https://doi.org/10.3390/nu12092628
  13. Probiotics as a Coadjuvant Factor in Active or Quiescent Inflammatory Bowel Disease of Adults—A Meta-Analytical Study vol.12, pp.9, 2015, https://doi.org/10.3390/nu12092628
  14. The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease vol.8, pp.11, 2020, https://doi.org/10.3390/microorganisms8111715
  15. Protein denature extracts of Lactobacillus crispatus KT‐11 strain promote interleukin 12p40 production via Toll‐like receptor 2 in J774.1 cell culture vol.45, pp.2, 2015, https://doi.org/10.1111/jfbc.13599
  16. Fecal Microbiome and Resistome Profiling of Healthy and Diseased Pakistani Individuals Using Next-Generation Sequencing vol.9, pp.3, 2021, https://doi.org/10.3390/microorganisms9030616
  17. The effects of probiotics, prebiotics and synbiotics on the reduction of IBD complications, a periodic review during 2009–2020 vol.130, pp.6, 2021, https://doi.org/10.1111/jam.14907
  18. Encapsulation of probiotics and nutraceuticals: Applications in functional food industry vol.114, pp.None, 2015, https://doi.org/10.1016/j.tifs.2021.05.022
  19. Probiotics Regulate Gut Microbiota: An Effective Method to Improve Immunity vol.26, pp.19, 2015, https://doi.org/10.3390/molecules26196076
  20. Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD vol.11, pp.12, 2021, https://doi.org/10.3390/biom11121903
  21. Probiotics in Gastrointestinal Diseases: All that Glitters Is Not Gold vol.40, pp.1, 2022, https://doi.org/10.1159/000516023